Dodge & Cox

Holding/activity history for  Regeneron Pharmaceuticals (REGN)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 1,555,285 1.45 $1,051.24
2024   Q2 1,555,285 1.54 $1,051.03
2024   Q1 1,555,285 1.38 $962.49
2023   Q4 1,555,285 1.41 $878.29
2023   Q3 1,555,285 1.40 Add 0.47% 0.01 $822.96
2023   Q2 1,548,085 1.22 Add 0.36% 0.00 $718.54
2023   Q1 1,542,485 1.44 Add 8.30% 0.11 $821.67
2022   Q4 1,424,285 1.18 $721.49
2022   Q3 1,424,285 1.38 Add 6.17% 0.08 $688.87
2022   Q2 1,341,485 0.94 $591.13
2022   Q1 1,341,485 0.97 Add 1135.15% 0.89 $698.42
2021   Q4 108,609 0.07 Buy 0.07 $631.52
2011   Q3 0 0 Sell 100.00% 0.02
2011   Q2 145,128 0.02 $56.71
2011   Q1 145,128 0.01 Buy 0.01 $44.94